Sandimmun Neoral 25 mg
Sandimmun Neoral 25 mg is a medicine authorised by Swissmedic under authorisation number 52656. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 May 1994 and the authorisation is valid without a time limit. ATC code L04AD01 places the medicine in the group Immunosuppressants.
| Authorisation number | 52656 |
|---|---|
| Name | Sandimmun Neoral 25 mg |
| Full name | Sandimmun Neoral 25 mg, Kapseln |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AD01 |
| First authorisation | 16 May 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sandimmun Neoral 25 mg, Kapseln | B | 16 May 1994 |
| 2 | Sandimmun Neoral 50 mg, Kapseln | B | 16 May 1994 |
| 3 | Sandimmun Neoral 100 mg, Kapseln | B | 16 May 1994 |
| 4 | Sandimmun Neoral 10 mg, Kapseln | B | 18 June 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 50 | Kapsel(n) | L04AD01 | 07.15.0. | B |
| 36 | 50 | Kapsel(n) | L04AD01 | 07.15.0. | B |
| 44 | 50 | Kapsel(n) | L04AD01 | 07.15.0. | B |
| 52 | 60 | Kapsel(n) | L04AD01 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sandimmun Neoral 25 mg authorised in Switzerland?
Yes. Sandimmun Neoral 25 mg is authorised by Swissmedic under authorisation number 52656, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sandimmun Neoral 25 mg have?
Sandimmun Neoral 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sandimmun Neoral 25 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.